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Pathogenic Staphylococcus aureus employs a cell-to-cell communication system to control virulence factor
expression in the host during infection. In this issue, Peterson et al. (2008) report that host lipoproteins can
sequester the S. aureus communication signal and antagonize virulence factor expression and pathogenesis
in a murine model of infection.ecember 11, 2008 ª2008 Elsevier Inc. 507Cell-to-cell communication allows bacte-
rial populations to coordinate gene ex-
pression and synchronize cellular events.
In bacterial pathogens, this regulatory
switch relies on the secretion of a signaling
molecule that is sensed by the cell popula-
tion and triggers the expression of viru-
lence determinants. Communication
signals reach the critical concentration at
a specific population density, or ‘‘quo-
rum’’ of cells, and thus this regulatory
mechanism is often termed ‘‘quorum
sensing.’’ To talk with neighbors, bacterial
pathogens need to secrete these signaling
molecules into the environment, providing
an extracellular avenue for interrupting
communication mechanisms. The lack
of membrane barriers has allowed re-
searchers to develop creative strategies
for inhibiting quorum-sensing through
direct inactivation of the signal or the
identification of compounds that compete
for the signal receptor. Therefore, quo-
rum-sensing antagonism is viewed as
a promising strategy for the discovery ofantipathogenic therapeutics that can aid
traditional approaches toward fighting
bacterial infection (Hentzer and Givskov,
2003).
Like many innovative ideas for combat-
ing bacterial pathogens, nature has al-
ready developed intriguing mechanisms
to antagonize quorum-sensing and thus
disrupt communication among microbes.
Gram-negative bacteria employ acyl-
homoserine lactone (AHL) signaling mech-
anisms, and marine alga produce furanone
compounds that compete for the AHL sig-
nal receptors on marine bacteria as well as
pathogens such as Pseudomonas aerugi-
nosa (Hentzer and Givskov, 2003). Soil
bacteria produce lactonase enzymes that
degrade the AHL compounds by opening
the lactone ring, and other bacteria pro-
duce acylases that remove the AHL fatty
acid tail. Mammalian immune systems
are not to be outdone in this regard, as
airway epithelia produce paraoxanase en-
zymes that inactivate AHL signals through
a lactonase mechanism (Ozer et al., 2005).
Cell Host & Microbe 4, DGram-positive bacteria also utilize quo-
rum-sensing for virulence factor regula-
tion, but the sensing mechanism differs
in that the signals are peptide based and
the signal receptors are surface localized.
An important subclass of peptide quorum-
sensing signals possesses an embedded
cyclic thiolactone or lactone ring structure
and is produced by diverse members of
the bacterial genera Staphylococcus and
Enterococcus (Lyon and Novick, 2004),
which include a number of prominent
opportunistic pathogens. One of the best
studied of these cyclic peptide-like struc-
tures is the autoinducing peptide (AIP) sig-
nal produced by Staphylococcus aureus.
AIP activates a regulatory cascade that
results in the repression of surface adhe-
sins and upregulation of secreted toxins
and invasive enzymes. This regulatory
system is often termed accessory gene
regulator (agr), and the agr response is
especially strong in emerging methicillin-
resistant S. aureus (MRSA) isolates. Con-
sidering that S. aureus is now the most
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bacterial infections (Klevens et al., 2007),
understanding invasion mechanisms and
host strategies to intercept these path-
ways remains an important area of future
research.
Like the AHL quorum-sensing, host
immune systems have already developed
strategies to combat S. aureus AIP signal-
ing. One of the earliest observations was
that low pH inhibits the quorum-sensing
response (Regassa et al., 1992), indicating
that several host tissue sites might have an
innate environmental control mechanism
to mediate antagonism. However, many
body sites, including the vasculature, are
maintained at neutral pH and remain
prone to S. aureus growth and infection
development. Interestingly, Yarwood and
colleagues observed that the quorum-
sensing response was inhibited by serum
(Yarwood et al., 2002), hinting that one or
more soluble factors in the circulation
has the capacity to undermine bacterial
communication. In this issue, Peterson
et al. (2008) discover a component of
blood, apoliprotein B (ApoB), that inhibits
S. aureus quorum-sensing by sequester-
ing the AIP signal. ApoB is one of the
largest monomeric proteins known and
is an integral structural component of
low-density lipoprotein (LDL) and very
low-density lipoprotein (VLDL), which are
large, multicomponent particles that cir-
culate at high concentrations in the blood.
ApoB is amphipathic in nature and pos-
sesses a pentapartite structure with an
amino terminal a-helical globular domain,
two flexible internal a-helical regions
with reversible lipid association, and two
b strand domains with irreversible lipid
affinity. The globular amino terminus is
surface exposed and represents a poten-
tial region for interaction with soluble
blood components. In initial studies of
the capacity of serum to quench quorum
sensing, Peterson et al. noted that lipopro-
tein-deficient serum failed to inhibit the
quorum response, leading to the testing
of individual lipoprotein components and
identification of ApoB as being sufficient
for the antagonism phenotype. ApoB did
not adhere to the S. aureus cell surface,
and followup analysis demonstrated that
ApoB was directly bound to the secreted
AIP signal (Figure 1). After hemoglobin,
ApoB represents the second blood com-
ponent identified that can attenuate the
quorum response under in vitro condi-
tions. Hemoglobin inhibition may involve
the AgrC-AgrA two-component system
that senses the AIP signal, but the details
of the inhibitory mechanism remain to be
fully clarified (Schlievert et al., 2007). Thus,
the data from Peterson et al. demonstrate
that ApoB utilizes a novel mechanism to
quench S. aureus quorum sensing.
To extend the relevance of their obser-
vations to the in vivo setting, Peterson
et al. (2008) evaluated ApoB antagonism
of quorum sensing in murine models of
staphylococcal infection. Mice deficient
in LDL receptor expression (Pcsk9/)
have low serum levels of ApoB and were
more susceptible to S. aureus infection,
but not when the infecting strains were
defective in quorum sensing. The drug
4-aminopyrazolo[3,4-d]pyrimidine (4-APP)
inhibits low-density lipoprotein secretion
in the liver, reducing ApoB levels, and
mice treated with 4-APP were also more
susceptible to S. aureus infection. Thus,
ApoB in the lipoprotein particle represents
a new component of innate immunity de-
fense against S. aureus infection. Impor-
tantly, the quorum-sensing antagonism
also operates against USA300 isolates,
the dominant isolate of the emerging com-
munity-associated MRSA strains (Klevens
et al., 2007).
Like all noteworthy reports, the studies
of Peterson et al. raise many new ques-
tions just as they provide novel insights.
The quorum-sensing response of
S. aureus contributes significantly to its
prowess as an invasive pathogen by
regulating its secretion of toxins, lipases,
proteases, and nucleases necessary for
spreading through tissues. How does the
successful pathogen counteract or evade
host quenching mechanisms such as
ApoB and still activate the quorum-sens-
ing system? Cell clumping to protect the
AIP molecule or internalization into cells,
where quorum sensing is known to be ac-
tive (Shompole et al., 2003), are possible
mechanisms, but the serum concentra-
tions of lipoproteins, including ApoB, fluc-
tuate acutely during infection. Other lipid
transfer proteins that accompany the
acute phase reaction might contribute to
sequestering quorum-sensing factors as
well. Given that neutrophils represent the
dominant cellular component of innate
host defense against pyogenic bacteria,
to what extent do quorum-sensing factors
or their quenching contribute to the patho-
genesis of S. aureus infection? Within
the neutrophil phagosome, oxidants
Figure 1. Host Defense Strategies Targeting Staphylococcus aureus Quorum Sensing
During growth, S. aureus synthesizes and secretes an autoinducing peptide (AIP) molecule that contains
a carboxy-terminal thiolactone ring. Once the AIP signal accumulates to a threshold concentration, it will
bind to the surface receptor (AgrC) and activate a regulatory cascade leading to the secretion of invasive
factors. Outside the cell, AIP is susceptible to multiple layers of innate immune defense mechanisms. As
outlined in this issue, Peterson et al. (2008) document a novel role for apoliprotein B (ApoB), an essential
structural component of low-density lipoprotein (LDL), in quorum-sensing antagonism. ApoB can seques-
ter AIP in the blood and quench the quorum response, attenuating an invasive S. aureus infection. Another
blood component, hemoglobin, is also thought to repress the quorum response in a manner that is not fully
defined. If S. aureus evades these innate barriers, neutrophils will ingest the invading pathogen and AIP is
oxidatively deactivated by reactive oxygen species (ROS) in the phagosome.508 Cell Host & Microbe 4, December 11, 2008 ª2008 Elsevier Inc.
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and granule proteins delivered by phago-
lysosome fusion create an environment
extremely inhospitable to ingested mi-
crobes. Among the toxic agents gener-
ated are HOCl, bleach, the oxidation prod-
uct of H2O2, and the granule protein
myeloperoxidase (MPO) in the presence
of chloride. The products of the NADPH
oxidase oxidatively deactivate the AIP
molecule (Rothfork et al., 2004) but also
oxidize lipoproteins and thus potentially
compromise interactions between ApoB
and AIP. Although acetylated LDL still
blocks quorum sensing by AIP, the MPO-
H2O2-chloride system supports a broad
array of posttranslational changes, includ-
ing tyrosine chlorination, oxidation of thiol-
containing targets, selective modification
of apoA-1 in high-density lipoprotein
(HDL), oxidation of tryptophan residues,
and oxidation of phosphoryl serine, etha-
nolamine, and choline. Given the potency
of species generated in the neutrophil
phagosome, the contribution of ApoB-
AIP interactions to quorum sensing of
ingested S. aureus merits further study.Malaria Pulls a FA
Maroya D. Spalding1 and Sean T. Prigge
1Department of Biochemistry and Molecular B
2Department of Molecular Microbiology and Im
Johns Hopkins Bloomberg School of Public H
*Correspondence: sprigge@jhsph.edu
DOI 10.1016/j.chom.2008.11.006
Cure of rodentmalaria with the biocid
this issue ofCell Host &Microbe, Yu
an important role specifically in mal
The malaria parasite Plasmodium falcipa-
rum infects two types of human host cells
during distinct stages of its life cycle. After
the bite of an infected Anopheles mos-
quito, malaria parasites infect hepato-
cytes, where they undergo a period of
explosive growth, multiplying 10,000-
fold. These parasites are then released
to the blood stream, where they invade
red blood cells and begin the cyclic eryth-
rocytic stage that is the cause of malariaIn summary, S. aureus employs quorum
sensing as critical regulatory mechanism
to shift the balance from a colonizing to
an invasive state. The triggering of this
switch could be detrimental to the host,
potentially leading to the evolution of in-
nate antagonistic mechanisms to repress
the response. Peterson et al. indicate that
ApoB may provide one mechanism that
operates through sequestering of the
AIP signal. Interestingly, ApoB also binds
to AIP structures composed of different
amino acids produced by other S. aureus
strains, but not linearized versions of AIP
peptides, suggesting that ApoB may
have general affinity for the cyclic moiety
of AIP molecules. Considering other
Gram-positive pathogens encode genes
to produce similar AIP structures (Lyon
and Novick, 2004), ApoB could serve as a
general host defense mechanism against
cyclic peptide based quorum sensing.
REFERENCES
Hentzer, M., and Givskov, M. (2003). J. Clin. Invest.
112, 1300–1307.St One
2,*
iology
munology
ealth, Baltimore, MD 21205, USA
e triclosan highlighted the enzyme F
et al. (2008) show that FabI is not the p
aria liver stage development.
morbidity and mortality. Parasite develop-
ment within these two very different cell
types while in the human host leads to fas-
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stage P. falciparum has long been known
to scavenge fatty acids from the host,
and these lipids are used in multiple pro-
cesses, including phospholipid and tria-
cylglycerol synthesis (Vial et al., 1982).
P. falciparum was believed to be an obli-
gate scavenger of fatty acids until a type
II fatty acid synthase (FAS II) was identified
in the genome, showing that malaria is
capable of de novo fatty acid synthesis
(Gardner et al., 1998; Waller et al., 1998).
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